Life expectancy for people with metastatic or metastasized lung cancer is low. The 5-year survival rate for small cell lung cancer is 3%, and 8% for non-small cell lung cancer (NSCLC). 25-30% of ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

Obesity is associated with an increased risk of developing breast cancer, and a greater probability for the cancer to spread ...

Radiographic disappearance of metastases could be a surrogate marker for outcomes among patients treated for metastatic ...

First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.

Panelists discuss the presentation and management of a case involving HER2-mutated metastatic non–-small cell lung cancer ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

By 2023, approximately 1 in 5 patients with non-small cell lung cancer or metastatic colorectal cancer were treated with a bevacizumab biosimilar.